34 related articles for article (PubMed ID: 8695244)
1. A modified recursive partitioning analysis for predicting overall survival in patients with non-small cell lung cancer and central nervous system metastases.
Muniz TP; de Jesus VHF; Sousa VAR; Barbosa MVDR; de Lima VCC
J Thorac Dis; 2019 Sep; 11(9):3909-3919. PubMed ID: 31656665
[TBL] [Abstract][Full Text] [Related]
2. Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer.
Turkaj A; Morelli AM; Vavalà T; Novello S
Front Oncol; 2018; 8():278. PubMed ID: 30140655
[TBL] [Abstract][Full Text] [Related]
3. Systemic treatment of non-small cell lung cancer brain metastases.
Cedrych I; Kruczała MA; Walasek T; Jakubowicz J; Blecharz P; Reinfuss M
Contemp Oncol (Pozn); 2016; 20(5):352-357. PubMed ID: 28373815
[TBL] [Abstract][Full Text] [Related]
4. State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer.
Inno A; Di Noia V; D'Argento E; Modena A; Gori S
Transl Lung Cancer Res; 2016 Dec; 5(6):599-609. PubMed ID: 28149755
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future.
Proto C; Imbimbo M; Gallucci R; Brissa A; Signorelli D; Vitali M; Macerelli M; Corrao G; Ganzinelli M; Greco FG; Garassino MC; Lo Russo G
Transl Lung Cancer Res; 2016 Dec; 5(6):563-578. PubMed ID: 28149752
[TBL] [Abstract][Full Text] [Related]
6. Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis.
Zheng MH; Sun HT; Xu JG; Yang G; Huo LM; Zhang P; Tian JH; Yang KH
Biomed Res Int; 2016; 2016():5807346. PubMed ID: 27006948
[TBL] [Abstract][Full Text] [Related]
7. The interactive association between heat shock factor 1 and heat shock proteins in primary myocardial cells subjected to heat stress.
Tang S; Chen H; Cheng Y; Nasir MA; Kemper N; Bao E
Int J Mol Med; 2016 Jan; 37(1):56-62. PubMed ID: 26719858
[TBL] [Abstract][Full Text] [Related]
8. Brain metastases: an overview.
Bertolini F; Spallanzani A; Fontana A; Depenni R; Luppi G
CNS Oncol; 2015; 4(1):37-46. PubMed ID: 25586424
[TBL] [Abstract][Full Text] [Related]
9. Systemic therapy of brain metastases.
Brastianos HC; Cahill DP; Brastianos PK
Curr Neurol Neurosci Rep; 2015; 15(2):518. PubMed ID: 25492479
[TBL] [Abstract][Full Text] [Related]
10. Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.
Lukas RV; Lesniak MS; Salgia R
CNS Oncol; 2014 Jan; 3(1):61-75. PubMed ID: 25054901
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer.
Sakamoto J; Sonobe M; Kobayashi M; Ishikawa M; Kikuchi R; Nakajima D; Yamada T; Nakayama E; Takahashi T; Sato T; Chen F; Bando T; Date H
Int J Clin Oncol; 2014 Feb; 19(1):50-6. PubMed ID: 23239054
[TBL] [Abstract][Full Text] [Related]
12. The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.
Olson JJ; Paleologos NA; Gaspar LE; Robinson PD; Morris RE; Ammirati M; Andrews DW; Asher AL; Burri SH; Cobbs CS; Kondziolka D; Linskey ME; Loeffler JS; McDermott M; Mehta MP; Mikkelsen T; Patchell RA; Ryken TC; Kalkanis SN
J Neurooncol; 2010 Jan; 96(1):115-42. PubMed ID: 19957013
[TBL] [Abstract][Full Text] [Related]
13. Treatment options for brain metastases in patients with non-small-cell lung cancer.
Taimur S; Edelman MJ
Curr Oncol Rep; 2003 Jul; 5(4):342-6. PubMed ID: 12781078
[TBL] [Abstract][Full Text] [Related]
14. Treatment options for brain metastases in patients with non-small cell lung cancer.
Taimur S; Edelman MJ
Curr Treat Options Oncol; 2003 Feb; 4(1):89-95. PubMed ID: 12525283
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer.
Cotto C; Berille J; Souquet PJ; Riou R; Croisile B; Turjman F; Giroux B; Brune J; Trillet-Lenoir V
Eur J Cancer; 1996 Jan; 32A(1):69-71. PubMed ID: 8695244
[TBL] [Abstract][Full Text] [Related]
16. Fotemustine in the treatment of brain primary tumors and metastases.
Khayat D; Giroux B; Berille J; Cour V; Gerard B; Sarkany M; Bertrand P; Bizzari JP
Cancer Invest; 1994; 12(4):414-20. PubMed ID: 8032964
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: preliminary report of a French multicentre phase II trial.
Rivière A; Le Cesne A; Berille J; Baio S; Le Chevalier T
Eur J Cancer; 1994; 30A(5):587-90. PubMed ID: 8080671
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer.
Pujol JL; Monnier A; Berille J; Cerrina ML; Douillard JY; Rivière A; Grandgirard A; Gouva S; Bizzari JP; Le Chevalier T
Br J Cancer; 1994 Jun; 69(6):1136-40. PubMed ID: 8198982
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603).
Galetta D; Gebbia V; Silvestris N; Ferraù F; Carrozza F; Cigolari S; Russo P; Calista F; Adamo V; Colucci G
Lung Cancer; 2011 Apr; 72(1):59-63. PubMed ID: 20728237
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
